High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: A systematic review with meta-analysis

This publication has 18 references indexed in Scilit:

• Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis
  The Lancet Oncology, 2013
• How I treat relapsed and refractory Hodgkin lymphoma
  Blood, 2011
• Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
  Journal of Clinical Oncology, 2010
• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
  Journal of Clinical Epidemiology, 2009
• Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma
  European Journal of Nuclear Medicine and Molecular Imaging, 2003
• Epidemiology and etiology of Hodgkin's lymphoma
  Annals of Oncology, 2002
• Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial
  The Lancet, 2002
• New Prognostic Score Based on Treatment Outcome of Patients With Relapsed Hodgkin's Lymphoma Registered in the Database of the German Hodgkin's Lymphoma Study Group
  Journal of Clinical Oncology, 2002
• Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
  Statistics in Medicine, 1998
• Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial
  The Lancet, 1993